MENU
+Compare
ATRC
Stock ticker: NASDAQ
AS OF
Jan 14, 04:59 PM (EDT)
Price
$37.34
Change
+$0.94 (+2.58%)
Capitalization
1.81B

ATRC AtriCure Forecast, Technical & Fundamental Analysis

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors... Show more

ATRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ATRC with price predictions
Jan 13, 2026

Momentum Indicator for ATRC turns negative, indicating new downward trend

ATRC saw its Momentum Indicator move below the 0 level on January 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In of the 77 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ATRC moved out of overbought territory on December 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on December 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATRC moved below its 50-day moving average on January 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in of 315 cases, the price rose further within the following month. The odds of a continued upward trend are .

ATRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 229 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.798) is normal, around the industry mean (11.802). P/E Ratio (0.000) is within average values for comparable stocks, (168.298). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.531). ATRC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (3.339) is also within normal values, averaging (113.639).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ATRC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATRC is expected to report earnings to rise 940.00% to -10 cents per share on February 24

AtriCure ATRC Stock Earnings Reports
Q4'25
Est.
$-0.10
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.13
The last earnings report on October 29 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 312.90K shares outstanding, the current market capitalization sits at 1.81B.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7555 Innovation Way
Phone
+1 513 755-4100
Employees
1200
Web
https://www.atricure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSGIX39.430.07
+0.18%
JPMorgan Mid Cap Growth A
PPSFX19.30-0.03
-0.16%
Principal Large Cap Value III R3
ESGYX22.51-0.09
-0.40%
Mirova Global Megatrends Y
MOSLX9.04-0.05
-0.55%
MassMutual Overseas Adm
OCHIX10.47-0.12
-1.13%
Oberweis China Opportunities Instl

ATRC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-3.29%
CERS - ATRC
42%
Loosely correlated
+11.01%
SIBN - ATRC
41%
Loosely correlated
+0.06%
MMSI - ATRC
40%
Loosely correlated
-2.61%
ISRG - ATRC
40%
Loosely correlated
-1.91%
IRMD - ATRC
38%
Loosely correlated
+1.38%
More

Groups containing ATRC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-3.29%
Pharmaceuticals: Other
industry (106 stocks)
41%
Loosely correlated
-0.12%
Pharmaceuticals
industry (383 stocks)
33%
Poorly correlated
+0.10%